Compare PBLS & LION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PBLS | LION |
|---|---|---|
| Founded | N/A | 1997 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 4.1B |
| IPO Year | 2026 | 2025 |
| Metric | PBLS | LION |
|---|---|---|
| Price | $31.63 | $13.26 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $11.89 |
| AVG Volume (30 Days) | 451.4K | ★ 2.3M |
| Earning Date | N/A | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,631,800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $22.98 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $25.56 | $5.65 |
| 52 Week High | $33.65 | $16.70 |
| Indicator | PBLS | LION |
|---|---|---|
| Relative Strength Index (RSI) | 57.89 | 42.10 |
| Support Level | $26.83 | $13.14 |
| Resistance Level | $33.65 | $14.78 |
| Average True Range (ATR) | 2.51 | 0.54 |
| MACD | 0.16 | -0.08 |
| Stochastic Oscillator | 69.57 | 15.31 |
Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.
Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.